J Rheum Dis.
2012 Aug;19(4):206-211. 10.4078/jrd.2012.19.4.206.
Dietary Flavonoid Apigenin is not Effective in Preventing Development of a Bleomycin-Induced Murine Model of Scleroderma
- Affiliations
-
- 1Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea. junjb@hanyang.ac.kr
- 2Department of Bioengineering, College of Engineering, Hanyang University, Seoul, Korea.
- 3Institute of Rheumatism, Hanyang University, Seoul, Korea.
- 4Department of Pathology, Hanyang University Medical Center, Seoul, Korea.
- 5Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
- KMID: 2223072
- DOI: http://doi.org/10.4078/jrd.2012.19.4.206
Abstract
OBJECTIVE
Systemic sclerosis is a connective tissue disease characterized by vasculopathy, excessive accumulation of extracellular matrix, and fibrosis of the skin and internal organs. The dietary flavonoid apigenin has been shown to reduce expression of the myofibroblast phenotype and to inhibit contraction of collagen gels. We investigated the effect of apigenin on the prevention and treatment of a modified bleomycin-induced animal model of scleroderma.
METHODS
Recently, we successfully induced scleroderma by weekly subcutaneous injections of bleomycin using a thermo-reversible combination gel composed of low molecular weight methylcellulose. A weekly subcutaneous injection of methylcellulose gel loaded with bleomycin induced focal skin fibrosis on the back skin and fibrotic phenotype of lung tissue in mice. The histologic examination of skin and lungs, collagen assay of lungs, and expression of connective tissue growth factor were investigated.
RESULTS
Daily intra-peritoneal injection of 1.0 mg/kg or 2.5 mg/kg of apigenin starting a week before the bleomycin injections failed to prevent the development of skin fibrosis and reduce the fibrotic phenotypes of skin and lung tissue.
CONCLUSION
Although some in vitro experiments have supported a potential role of apigenin in the treatment of fibrosis, dietary flavonoid apigenin is not effective in preventing development of a bleomycin-induced murine model of scleroderma.
Keyword
MeSH Terms
-
Animals
Apigenin
Bleomycin
Collagen
Connective Tissue Diseases
Connective Tissue Growth Factor
Contracts
Extracellular Matrix
Fibrosis
Gels
Injections, Subcutaneous
Lung
Methylcellulose
Mice
Models, Animal
Molecular Weight
Myofibroblasts
Phenotype
Scleroderma, Systemic
Skin
Apigenin
Bleomycin
Collagen
Connective Tissue Growth Factor
Gels
Methylcellulose
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A case of bleomycin-induced scleroderma
- The Therapeutic Efficacy of Apigenin in a Murine Model of Scleroderma
- Induction of Animal Model of Scleroderma with Repeated Injection of Bleomycin
- A Case of Bleomycin induced Streaky Pigmentation and Scleroderma
- Anti-fibrotic Effect of Silibinin in Keloid Fibroblasts and a Bleomycin-induced, Scleroderma-like Animal Model
